Questcor Pharmaceuticals (NASDAQ:QCOR)
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
drugs, everybody loves drugs. seriously tho, i think the next bubble is going to be the over-medicating bubble!
Recs
Questcor is on a Quest to get CRUSHED. Questcrush?
Recs
Questcor recently posted earnings of 45 cents per share for the fourth quarter, up 697% from the same quarter one year ago. Questcor has also repurchased their shares from Shire Pharmaceuticals, possibly pointing to a takeover worth $937.5 million, based on past purchases made by Shire, equating to approximately $12.5 per share. Although there is no word from Questcor stating this, it does appear entirely possible. Questcor also has a new drug in the pipeline, an orally dissolvable treatment for pain, which would put them in a $1.9 billion annual market.
Recs
Based on 6 month evaluation of chart, this stock has already well-outperformed the S&P
Recs
Restructuring is growing cash at $8 million per month (25% of market cap will be cash in one year), debt free, new drugs in pipeline, pursuing a blockbuster that will take 2 years to develop-which in drug land is very quick.
Recs
what goes up must come down
Recs
Theyre in debt. Terrible financials. In need of better management.
Recs
technical short after pop on MS drug sales growth - current price unsustainable
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 41 - 48 of 48 : « Previous 1 2 3